首页 / 院系成果 / 成果详情页

Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China Findings From the Improving CCC Project (Care for Cardiovascular Disease in China)  期刊论文  

  • 编号:
    a874e6d6-3248-4052-b3c3-61cc3376e1eb
  • 作者:
    Yang, Qing[1,2];Wang, Ying[1];Liu, Jing[1];Liu, Jun[1];Hao, Yongchen;Smith, Sidney C., Jr.[3];Huo, Yong;Fonarow, Gregg C.[4];Ma, Changsheng[2];Ge, Junbo(葛均波)[5]Taubert, Kathryn A.[6];Morgan, Louise[7];Guo, Yang[1];Wang, Wei[1];Zhou, Yujie[2];Zhao, Dong[1];
  • 语种:
    English
  • 期刊:
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS ISSN:1941-7640 2017 年 10 卷 6 期 ; JUN
  • 收录:
  • 关键词:
  • 摘要:

    Background-Early invasive strategies and antithrombotic treatments are key treatments of non-ST-segment-elevation acute coronary syndrome (NSTE-ACS). Few studies have examined the use of these strategies in patients with NSTE-ACS in China. This study aimed to assess the applications of invasive strategies and antithrombotic treatments in patients with NSTE-ACS and compare their outcomes. Methods and Results-A nationwide registry study, Improving CCC (Care for Cardiovascular Disease in China) ACS project, was launched in 2014 as a collaborative study of the American Heart Association and Chinese Society of Cardiology (CSC), with 142 participating hospitals reporting details of clinical management and outcomes of patients with NSTE-ACS. The use of invasive strategies and antithrombotic treatments was examined based on updated guidelines. Major adverse cardiovascular events were analyzed. A total of 9953 patients with NSTE-ACS were enrolled. Angiography was performed in 63.1% of these patients, and 58.2% underwent percutaneous coronary intervention (PCI). However, 40.6% of patients did not undergo early risk assessment, and very-high-risk patients had the lowest proportion of PCI (41.7%). PCI was performed within recommended times in 11.1% of very-high-risk patients and 26.3% of high risk patients. Those who underwent PCI within 2 hours had higher mortality in high-risk and very-high-risk patients who received PCI. Early dual antiplatelet treatment was given in 88.3% of patients. Conclusions-There are notable differences between guideline recommendations and the clinical management of patients with NSTE-ACS in China. The reasons for very-high-risk NSTE-ACS patients not undergoing PCI, and the optimal timing of PCI, require further clarification.

  • 推荐引用方式
    GB/T 7714:
    Yang Qing,Wang Ying,Liu Jing, et al. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China Findings From the Improving CCC Project (Care for Cardiovascular Disease in China) [J].CIRCULATION-CARDIOVASCULAR INTERVENTIONS,2017,10(6).
  • APA:
    Yang Qing,Wang Ying,Liu Jing,Liu Jun,&Zhao Dong.(2017).Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China Findings From the Improving CCC Project (Care for Cardiovascular Disease in China) .CIRCULATION-CARDIOVASCULAR INTERVENTIONS,10(6).
  • MLA:
    Yang Qing, et al. "Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China Findings From the Improving CCC Project (Care for Cardiovascular Disease in China)" .CIRCULATION-CARDIOVASCULAR INTERVENTIONS 10,6(2017).
浏览次数:3 下载次数:0
浏览次数:3
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部